Literature DB >> 29383614

Comparison of odor identification among amnestic and non-amnestic mild cognitive impairment, subjective cognitive decline, and early Alzheimer's dementia.

Sung-Jin Park1, Jee-Eun Lee1, Kwang-Soo Lee1, Joong-Seok Kim2.   

Abstract

Olfactory impairment might be an important clinical marker and predictor of Alzheimer's disease (AD). In the present study, we aimed to compare the degree of olfactory identification impairment in each mild cognitive impairment (MCI) subtype, subjective memory impairment, and early AD dementia and assessed the relationship between olfactory identification and cognitive performance. We consecutively included 50 patients with amnestic MCI, 28 patients with non-amnestic MCI, 20 patients with mild AD, and 17 patients with subjective memory impairment (SMI). All patients underwent clinical and neuropsychological assessments. A multiple choice olfactory identification cross-cultural smell identification test was also utilized. Controlling for age and gender, olfactory impairment was significantly more severe in patients with AD and amnestic MCI compared with the results from the non-amnestic MCI and SMI groups. Higher scores on MMSE, verbal and non-verbal memory, and frontal executive function tests were significantly related to olfactory identification ability. In conclusion, olfactory identification is impaired in amnestic MCI and AD. These findings are consistent with previous studies. In amnestic MCI patients, this dysfunction is considered to be caused by underlying AD pathology.

Entities:  

Keywords:  Alzheimer’s disease; Amnestic; Hyposmia; Mild cognitive impairment; Non-amnestic; Subjective memory impairment

Mesh:

Year:  2018        PMID: 29383614     DOI: 10.1007/s10072-018-3261-1

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  64 in total

1.  Volume loss of the medial temporal lobe structures in subjective memory impairment.

Authors:  Nadine Striepens; Lukas Scheef; Andrea Wind; Julius Popp; Annika Spottke; Déirdre Cooper-Mahkorn; Husam Suliman; Michael Wagner; Hans H Schild; Frank Jessen
Journal:  Dement Geriatr Cogn Disord       Date:  2010-01-28       Impact factor: 2.959

2.  Odor identification and self-reported olfactory functioning in patients with subtypes of mild cognitive impairment.

Authors:  Johann Lehrner; Gisela Pusswald; Andreas Gleiss; Eduard Auff; Peter Dal-Bianco
Journal:  Clin Neuropsychol       Date:  2009-02-11       Impact factor: 3.535

3.  Odor identification in mild cognitive impairment subtypes.

Authors:  Holly James Westervelt; Jared M Bruce; William G Coon; Geoffrey Tremont
Journal:  J Clin Exp Neuropsychol       Date:  2008-02       Impact factor: 2.475

4.  Subjective cognition and amyloid deposition imaging: a Pittsburgh Compound B positron emission tomography study in normal elderly individuals.

Authors:  Audrey Perrotin; Elizabeth C Mormino; Cindee M Madison; Amynta O Hayenga; William J Jagust
Journal:  Arch Neurol       Date:  2012-02

5.  Odor identification deficits in diffuse lewy body disease.

Authors:  Holly James Westervelt; Robert A Stern; Geoffrey Tremont
Journal:  Cogn Behav Neurol       Date:  2003-06       Impact factor: 1.600

6.  AD dementia risk in late MCI, in early MCI, and in subjective memory impairment.

Authors:  Frank Jessen; Steffen Wolfsgruber; Birgitt Wiese; Horst Bickel; Edelgard Mösch; Hanna Kaduszkiewicz; Michael Pentzek; Steffi G Riedel-Heller; Tobias Luck; Angela Fuchs; Siegfried Weyerer; Jochen Werle; Hendrik van den Bussche; Martin Scherer; Wolfgang Maier; Michael Wagner
Journal:  Alzheimers Dement       Date:  2013-01-30       Impact factor: 21.566

7.  Odor identification as an early marker for Alzheimer's disease: impact of lexical functioning and detection sensitivity.

Authors:  C D Morgan; S Nordin; C Murphy
Journal:  J Clin Exp Neuropsychol       Date:  1995-10       Impact factor: 2.475

8.  Presence of both odor identification and detection deficits in Alzheimer's disease.

Authors:  R L Doty; P F Reyes; T Gregor
Journal:  Brain Res Bull       Date:  1987-05       Impact factor: 4.077

9.  The nature and course of olfactory deficits in Alzheimer's disease.

Authors:  M Serby; P Larson; D Kalkstein
Journal:  Am J Psychiatry       Date:  1991-03       Impact factor: 18.112

Review 10.  Olfactory bulb involvement in neurodegenerative diseases.

Authors:  Johannes Attems; Lauren Walker; Kurt A Jellinger
Journal:  Acta Neuropathol       Date:  2014-02-20       Impact factor: 17.088

View more
  11 in total

Review 1.  Topographical disorientation in aging. Familiarity with the environment does matter.

Authors:  Antonella Lopez; Alessandro O Caffò; Andrea Bosco
Journal:  Neurol Sci       Date:  2018-06-12       Impact factor: 3.307

2.  Clinical significance of the cognition-related pathogenic proteins in plasma neuronal-derived exosomes among normal cognitive adults over 45 years old with olfactory dysfunction.

Authors:  Zirong Chen; FeiFan Chang; Linyin Yao; Fan Yuan; Junsheng Hong; Dawei Wu; Yongxiang Wei
Journal:  Eur Arch Otorhinolaryngol       Date:  2021-10-24       Impact factor: 2.503

3.  Olfaction and Executive Cognitive Performance: A Systematic Review.

Authors:  Vasudeva Murthy Challakere Ramaswamy; Peter William Schofield
Journal:  Front Psychol       Date:  2022-05-09

4.  Amyloid deposition and CBF patterns predict conversion of mild cognitive impairment to dementia.

Authors:  Takayuki Kikukawa; Takato Abe; Suzuka Ataka; Haruna Saito; Itsuki Hasegawa; Toshikazu Mino; Jun Takeuchi; Joji Kawabe; Yasuhiro Wada; Yasuyoshi Watanabe; Yoshiaki Itoh
Journal:  Neurol Sci       Date:  2018-06-23       Impact factor: 3.307

5.  The utility of olfactory function in distinguishing early-stage Alzheimer's disease from HIV-associated neurocognitive disorders.

Authors:  Erin E Sundermann; Adam Fields; Rowan Saloner; Ben Gouaux; Ajay Bharti; Claire Murphy; David J Moore
Journal:  AIDS       Date:  2021-03-01       Impact factor: 4.632

6.  Effect of A/T/N imaging biomarkers on impaired odor identification in Alzheimer's disease.

Authors:  Min Seok Baek; Hanna Cho; Hye Sun Lee; Jae Hoon Lee; Young Hoon Ryu; Chul Hyoung Lyoo
Journal:  Sci Rep       Date:  2020-07-14       Impact factor: 4.379

7.  Clinical impact of 11C-Pittsburgh compound-B positron emission tomography in addition to magnetic resonance imaging and single-photon emission computed tomography on diagnosis of mild cognitive impairment to Alzheimer's disease.

Authors:  Kazuhiro Kitajima; Kazuo Abe; Masanaka Takeda; Hiroo Yoshikawa; Mana Ohigashi; Keiko Osugi; Hidenori Koyama; Koichiro Yamakado
Journal:  Medicine (Baltimore)       Date:  2021-01-22       Impact factor: 1.889

Review 8.  Olfactory impairment in men and mice related to aging and amyloid-induced pathology.

Authors:  Wen-Yu Tzeng; Katherine Figarella; Olga Garaschuk
Journal:  Pflugers Arch       Date:  2021-02-20       Impact factor: 3.657

Review 9.  Personalizing the Care and Treatment of Alzheimer's Disease: An Overview.

Authors:  Dubravka Svob Strac; Marcela Konjevod; Marina Sagud; Matea Nikolac Perkovic; Gordana Nedic Erjavec; Barbara Vuic; Goran Simic; Vana Vukic; Ninoslav Mimica; Nela Pivac
Journal:  Pharmgenomics Pers Med       Date:  2021-05-28

Review 10.  The scent of emotions: A systematic review of human intra- and interspecific chemical communication of emotions.

Authors:  Elisa Calvi; Umberto Quassolo; Massimiliano Massaia; Anna Scandurra; Biagio D'Aniello; Patrizia D'Amelio
Journal:  Brain Behav       Date:  2020-03-25       Impact factor: 2.708

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.